Generic Drug Approval Standards Cases in D.C. Circuit

Browse 1 generic drug approval standards cases decided by D.C. Circuit. AI-powered summaries, holdings, and legal analysis.

1
Cases
1
Mixed

Generic Drug Approval Standards Opinions from D.C. Circuit (1)

Vanda Pharmaceuticals, Inc. v. FDA

D.C. Circuit Vacates FDA's Rejection of Vanda's Hetlioz sNDA

D.C. Circuit · 2025-08-15 · Mixed · Impact: 65/100

Vanda Pharmaceuticals, Inc. v. FDA, decided by D.C. Circuit on August 15, 2025, resulted in a mixed outcome. The D.C. Circuit reviewed the FDA's refusal to approve Vanda Pharmaceuticals' supplemental ...

Frequently Asked Questions

Q: How many generic drug approval standards cases has D.C. Circuit decided?

CaseLawBrief currently tracks 1 generic drug approval standards cases from D.C. Circuit. This number is updated as new opinions are published.

Q: What types of outcomes occur in generic drug approval standards cases at D.C. Circuit?

Outcome breakdown: Mixed: 1.

Q: Where can I find plain English summaries of generic drug approval standards rulings from D.C. Circuit?

Each case page on CaseLawBrief includes an AI-generated plain English summary, key holdings, and legal analysis. Click any case above to read its full analysis.

Explore More

All D.C. Circuit Cases All Generic Drug Approval Standards Cases All Courts All Topics Search